在Telitacicept在自身免疫性疾病的应用中的最新进展
Baocheng Liu1, Yaqi Zhao2, Dongxia Liu1
1Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, People's Republic of China.
Drug design, development and therapy
|December 12, 2024
概括
泰利塔西塞普是一种新的生物向B淋巴细胞激活因子 (BAFF) 和诱导增殖的配体 (APRIL) 的新型生物向药物,在SLE等自身免疫性疾病中显示出已证明的疗效和安全性. 进一步的研究将澄清最佳治疗时间.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 幽默免疫是自身免疫性疾病发病的核心.
- B淋巴细胞激活因子 (BAFF) 和诱导增殖的配体 (APRIL) 对B细胞调节和幽默免疫非常重要.
- 对BAFF和APRIL的失调有助于自身免疫性疾病.
研究的目的:
- 为了审查telitacicept的作用机制,药理动力学和临床疗效.
- 讨论telitacicept在各种自身免疫性疾病中的治疗潜力.
- 为突出目前的临床应用和未来的研究方向为telitacicept.
主要方法:
- 关于telitacicept的现有文献的审查.
- 对临床前和临床试验数据的分析.
- 已批准的指示和正在进行的调查的摘要.
主要成果:
- 泰利塔西塞普是中国首个被批准用于SLE的双位,三通道生物药物.
- 临床实践已经证明了telitacicept在治疗自身免疫性疾病中的有效性和安全性.
- 泰利塔西塞普针对BAFF和APRIL,这些细胞因子在B细胞平衡中至关重要.
结论:
- 泰利塔西塞普在治疗自身免疫性疾病方面已经确立了有效性和安全性.
- 启动和中止特利塔西塞普治疗的最佳时间需要进一步调查.
- 泰利塔西在治疗自身免疫性疾病方面取得了重大进展.
更多相关视频
相关概念视频
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
T Cell Types and Functions
951
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
951


![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)